Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, Parks JS.
Timmins JM, et al. Among authors: smith tl.
J Clin Invest. 2005 May;115(5):1333-42. doi: 10.1172/JCI23915. Epub 2005 Apr 7.
J Clin Invest. 2005.
PMID: 15841208
Free PMC article.